| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,929 |
5,312 |
$394K |
| 99199 |
Unlisted special service, procedure or report |
12,407 |
6,450 |
$79K |
| 99215 |
Prolong outpt/office vis |
702 |
616 |
$41K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
381 |
301 |
$15K |
| 87637 |
Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV |
76 |
52 |
$9K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
28 |
24 |
$3K |
| 99490 |
Ccm add 20min |
311 |
273 |
$2K |
| 36415 |
Collection of venous blood by venipuncture |
1,081 |
890 |
$2K |
| 99070 |
|
213 |
128 |
$1K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
154 |
120 |
$1K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
144 |
83 |
$1K |
| 99406 |
|
99 |
61 |
$842.80 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
75 |
63 |
$551.96 |
| 96127 |
|
153 |
127 |
$443.68 |
| 90688 |
|
82 |
52 |
$343.35 |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
22 |
14 |
$286.30 |
| 80061 |
Lipid panel |
12 |
12 |
$132.24 |
| 90715 |
|
28 |
14 |
$125.60 |
| 90686 |
|
34 |
24 |
$88.70 |
| 81003 |
|
78 |
69 |
$83.10 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
16 |
13 |
$38.43 |
| 3008F |
|
10,017 |
7,442 |
$0.54 |
| 1160F |
|
10,059 |
7,501 |
$0.51 |
| 1159F |
|
8,517 |
6,274 |
$0.50 |
| 3074F |
|
3,756 |
2,735 |
$0.36 |
| 3078F |
|
3,222 |
2,331 |
$0.30 |
| 1125F |
|
2,265 |
1,856 |
$0.12 |
| 3079F |
|
1,079 |
816 |
$0.06 |
| 4010F |
|
569 |
471 |
$0.03 |
| 3075F |
|
395 |
296 |
$0.01 |
| 1126F |
|
89 |
74 |
$0.01 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
960 |
826 |
$0.01 |
| 1000F |
|
3,110 |
2,270 |
$0.00 |
| 1036F |
|
916 |
612 |
$0.00 |
| 1034F |
|
890 |
657 |
$0.00 |
| 90733 |
|
27 |
13 |
$0.00 |
| 1031F |
|
127 |
96 |
$0.00 |
| G8754 |
Most recent diastolic blood pressure < 90 mmhg |
202 |
186 |
$0.00 |
| G9902 |
Patient screened for tobacco use and identified as a tobacco user |
31 |
27 |
$0.00 |
| 94760 |
|
51 |
47 |
$0.00 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
97 |
78 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
49 |
44 |
$0.00 |
| G0008 |
Administration of influenza virus vaccine |
17 |
17 |
$0.00 |
| 1032F |
|
773 |
552 |
$0.00 |
| G8753 |
Most recent systolic blood pressure >= 140 mmhg |
19 |
12 |
$0.00 |
| 1033F |
|
1,061 |
729 |
$0.00 |
| 3077F |
|
80 |
67 |
$0.00 |
| 98960 |
|
113 |
93 |
$0.00 |
| G8752 |
Most recent systolic blood pressure < 140 mmhg |
158 |
145 |
$0.00 |
| 3725F |
|
405 |
297 |
$0.00 |
| G8417 |
Bmi is documented above normal parameters and a follow-up plan is documented |
335 |
288 |
$0.00 |
| 4013F |
|
17 |
16 |
$0.00 |
| G9509 |
Adult patients 18 years of age or older with major depression or dysthymia who reached remission at twelve months as demonstrated by a twelve month (+/-60 days) phq-9 or phq-9m score of less than 5 |
39 |
36 |
$0.00 |
| G0444 |
Annual depression screening, 5 to 15 minutes |
13 |
12 |
$0.00 |